Search research articles
Contact Us
Filters
Showing results (71-80 of 232) with videos related to
Page
of 24
Sort By:
Thyroid : Official Journal of the American Thyroid Association
|
September 16, 2008
A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles
Raymond S Douglas, Robert A Goldberg, Terry J Smith
The Journal of Biological Chemistry
|
May 18, 2011
Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease
Shanli Tsui, Roshini Fernando, Beiling Chen, et al.
BMC Bioinformatics
|
January 29, 2015
Alignment-free clustering of transcription factor binding motifs using a genetic-k-medoids approach
Pilib Ó Broin, Terry J Smith, Aaron Aj Golden
Endocrine Reviews
|
December 13, 2003
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy
Bellur S Prabhakar, Rebecca S Bahn, Terry J Smith
Cytokine
|
March 12, 2002
Molecular cloning of an IL-8-like CXC chemokine and tissue factor in rainbow trout (Oncorhynchus mykiss) by use of suppression subtractive hybridization
Amaia Sangrador-Vegas, Jessica B Lennington, Terry J Smith
American Journal of Obstetrics and Gynecology
|
January 30, 2008
The relaxant effect of nifedipine in human uterine smooth muscle and the BK(Ca) channel
Audrey T Moynihan, Terry J Smith, John J Morrison
Thyroid : Official Journal of the American Thyroid Association
|
August 30, 2017
Response to Krieger et al. re: "TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746-747)
Terry J Smith, Joseph A M J L Janssen
Clinical Diabetes and Endocrinology
|
July 14, 2017
Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface
Priscila Novaes, Ana Beatriz Diniz Grisolia, Terry J Smith
Expert Opinion on Investigational Drugs
|
May 21, 2020
Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy
Dane H Slentz, Christine C Nelson, Terry J Smith
Nature Reviews. Endocrinology
|
May 13, 2024
Hearing abnormalities in patients treated with teprotumumab
Jason A Brant, Don O Kikkawa, Terry J Smith
Page
of 24
Search research articles
Search
Showing results (71-80 of 232) with videos related to
Sort By:
Page
of 24
Thyroid : Official Journal of the American Thyroid Association
|
September 16, 2008
A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles
Raymond S Douglas, Robert A Goldberg, Terry J Smith
The Journal of Biological Chemistry
|
May 18, 2011
Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease
Shanli Tsui, Roshini Fernando, Beiling Chen, et al.
BMC Bioinformatics
|
January 29, 2015
Alignment-free clustering of transcription factor binding motifs using a genetic-k-medoids approach
Pilib Ó Broin, Terry J Smith, Aaron Aj Golden
Endocrine Reviews
|
December 13, 2003
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy
Bellur S Prabhakar, Rebecca S Bahn, Terry J Smith
Cytokine
|
March 12, 2002
Molecular cloning of an IL-8-like CXC chemokine and tissue factor in rainbow trout (Oncorhynchus mykiss) by use of suppression subtractive hybridization
Amaia Sangrador-Vegas, Jessica B Lennington, Terry J Smith
American Journal of Obstetrics and Gynecology
|
January 30, 2008
The relaxant effect of nifedipine in human uterine smooth muscle and the BK(Ca) channel
Audrey T Moynihan, Terry J Smith, John J Morrison
Thyroid : Official Journal of the American Thyroid Association
|
August 30, 2017
Response to Krieger et al. re: "TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746-747)
Terry J Smith, Joseph A M J L Janssen
Clinical Diabetes and Endocrinology
|
July 14, 2017
Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface
Priscila Novaes, Ana Beatriz Diniz Grisolia, Terry J Smith
Expert Opinion on Investigational Drugs
|
May 21, 2020
Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy
Dane H Slentz, Christine C Nelson, Terry J Smith
Nature Reviews. Endocrinology
|
May 13, 2024
Hearing abnormalities in patients treated with teprotumumab
Jason A Brant, Don O Kikkawa, Terry J Smith
Page
of 24